2006 News

  • Worldwide Demand for L-Glutamine

    The increasing worldwide demand and rising energy costs for the production of L-Glutamine at Kyowa Hakko's facility (BioKyowa, Inc.) in Cape Girardeau, Missouri, has resulted in a price increase for all oral grade forms of L-Glutamine from Kyowa Hakko USA.

    View news »
  • Kyowa Hakko Develops White Paper Kit Featuring Amino Acids and Related Compounds for Release Throughout 2007

    December 8, 2006 New York, NY – Kyowa Hakko, the first global company to successfully produce and commercialize amino acids using proprietary fermentation methods, has announced development of a white paper kit to initially include six ingredient white papers. The white paper kit and first product paper focusing on Citicoline, will be available in December, with other ingredient white papers distributed throughout 2007. Kyowa Hakko, the amino acid manufacturing leader who has introduced a wide range of fermentation-based amino acids, developed the white paper kit in conjunction with Kyowa...

    View news »
  • Kyowa Hakko USA Introduces Setria® Glutathione

    October 16, 2006 New York, NY – Kyowa Hakko USA has launched the newest addition to their family of branded ingredients, Setria® Glutathione, recognized as an indispensable and versatile antioxidant. The announcement was made by Charlie Kotani, president, Kyowa Hakko USA. The most basic and abundant antioxidant within the body system, Setria® Glutathione is a tri-peptide composed of glutamic acid, cysteine and glycine. The key benefit of the ingredient is its ability to bind to organic toxins, as well as heavy metals, solvents and pesticides, and transform them into a form that can be excr...

    View news »
  • Kyowa Hakko the Original CoQ10 Marketer to Relaunch its Patented Ingredient

    September 13, 2006 New York, NY - Kyowa Hakko has commenced manufacturing Coenzyme Q10 (CoQ10) at its production facility in Hofu, Japan, and re-launched sales of Kyowa CoQ10™ to the U.S. nutraceutical marketplace. Kyowa Hakko is an international health ingredients manufacturer and world leader in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products. A pioneer in the development and application of fermentation technology, Kyowa Hakko has maintained a constant commitment to research and developing innovative products. Kyowa has developed a patente...

    View news »
  • Kyowa Hakko Sponsors Strawberry Afternoon Social and Two VendorWorks Seminars at SupplySide West

    September 13, 2006 New York, NY - Kyowa Hakko, the international health ingredients manufacturer and world leader in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products is sponsoring the Strawberry Afternoon Social and two VendorWorks seminars at SupplySide West. On Thursday, October 19, from 1:30 - 3:30 p.m., Kyowa will host the Strawberry Afternoon Social at booth #6013. Show attendees are invited to indulge in hand dipped chocolate covered strawberries as Kyowa celebrates the return of Kyowa CoQ10™. Kyowa, supplying CoQ10 globally, became t...

    View news »
  • Kyowa Hakko and NSF International Co-Sponsor <em>Run For the Health of It</em> at Expo East

    September 13, 2006 New York, NY - Get warmed up before hitting the show floor at Expo East. Join co-sponsors Kyowa Hakko and NSF International, as well as your friends and colleagues at Run For the Health of It, a run/walk around Baltimore's beautiful Inner Harbor on Friday, October 6 from 8-9 a.m. The event starts outside the Pratt Street lobby of the Baltimore Convention Center. Each participant receives a t-shirt and goodie bag, and is eligible to win an iPod Sport Kit. Pre-register by sending your name, company, phone, fax and email address to inquiry@kyowa-usa.com. Kyowa Hakko, the i...

    View news »
  • Kyowa Hakko Forms New Healthcare Product Development Center

    August 16, 2006 New York, NY – Kyowa Hakko has announced it has formed the HealthCare Product Development Center in Tsukuba, Japan, to focus on basic and application research, formulation and development, information services and marketing. The center will be under the direction of Kazuhiro Yamamoto for Kyowa Hakko in Tokyo, Japan. The center, situated in the heart of the well-known research and science-based town often referred to as Tsukuba Science City, will be home to 40 Kyowa researchers dedicated to supporting new Kyowa product development. “This is yet another way Kyowa is taking...

    View news »
  • Kyowa Hakko Introduces Hydrafend™ Sodium Hyaluronate Acid

    April 25, 2006 New York, N.Y. – Continuing its trend toward introducing branded ingredients, Kyowa Hakko USA has introduced Hydrafend™ a low Sodium Hyaluronate Acid that is a natural, animal-free fermentation-based ingredient. In the human body, Hyaluronate Acid is found in high concentrations in the skin, connective tissues, joints and eye fluids. Hydrafend™ functions as a lubricant and highly effective moisturizer. With age, the levels of Hyaluronate Acid in the body decrease, causing considerable reduction in the moisture binding capacity resulting in dry skin and joints. One of the ...

    View news »
  • Kyowa Hakko Unveils Lumistor™

    April 10, 2006 New York, NY – Kyowa Hakko USA, the makers of Cognizin™ brand citicoline has announced the launch its newest branded ingredient Lumistor™ L-Hydroxyproline, a natural, animal-free fermentation-based amino acid. The benefits of Lumistor™ include moisture retention of skin and proliferation of newborn human epidermal keratinocytes. Lumistor™ is a pure, odorless, white crystalline powder that is water soluble and stable across a broad pH range enabling its application within a wide array of cosmetics and toiletries. Lumistor™ has a proven safety record for topical and oral use....

    View news »
  • Citicoline Featured as a New Ingredient in the Textbook of Natural Medicine

    March 18, 2006 Tacoma, WA – The Textbook of Natural Medicine, Third Edition, 2006 published by Churchill Livingstone, a division of Elsevier Science, the world’s largest technical and medical publisher, has released a two-volume, 2,200 page book featuring a chapter on citicoline by Alexander Schauss, Ph.D., director of Natural and Medicinal Products Research for AIBMR Life Sciences, Inc. Citicoline (cytidine 5′-diphoscholine) is an important organic molecule that functions as an intermediate in the biosynthesis of cell membrane phospholipids. “There are over 550 published studies on citicol...

    View news »